Earnings and regulatory updates shape the latest view on CME Group

CME Group (CME) just posted first quarter earnings with revenue of US$1,880.1 million and net income of US$1,154.3 million, alongside regulatory approval for an expanded cross margining arrangement with the Depository Trust & Clearing Corporation.

At a share price of US$287.27, CME Group has posted a 6.52% year to date share price return. The 1 year total shareholder return of 7.63% and very large 3 year total shareholder return suggest momentum has been built over a longer period, with recent earnings and the expanded cross margining arrangement likely feeding into shifting expectations around growth and risk.

If CME Group’s recent updates have you thinking about where capital might move next, it could be worth scanning for other exchange exposed or trading related names via the 22 cryptocurrency and blockchain stocks

With CME Group posting higher quarterly revenue and earnings and sitting roughly 7% below the average analyst price target, the key question now is whether the current valuation leaves upside on the table or already reflects future growth.

Most Popular Narrative: 6.8% Undervalued

With CME Group last closing at $287.27 against a narrative fair value of $308.20, the current price sits below what that widely followed view implies.

The ongoing global shift toward electronic trading, greater regulatory demands for transparency and standardized clearing, and a proven ability to grow non-transactional revenue (e.g., record market data revenue) position CME to capture a larger share of trading activity and support durable long-term earnings growth.

Curious what kind of revenue trajectory and margin profile justify that higher fair value? The narrative leans on specific growth rates, profitability assumptions, and a future earnings multiple that may surprise you.

Result: Fair Value of $308.20 (UNDERVALUED)

However, this hinges on volatility and volumes holding up, while DeFi style platforms and lower fee rivals could still reduce CME Group’s share and pricing power.

Another way to look at valuation

That 6.8% “undervalued” narrative sits awkwardly next to the SWS DCF model, which points to a fair value of about $242.46 versus the current $287.27. On that view, CME Group screens as overvalued, not undervalued. This raises a simple question for you: are the cash flow assumptions too cautious, or is the market paying up for quality?

Simply Wall St performs a discounted cash flow (DCF) on every stock in the world every day (check out CME Group for example). We show the entire calculation in full. You can track the result in your watchlist or portfolio and be alerted when this changes, or use our stock screener to discover 53 high quality undervalued stocks. If you save a screener we even alert you when new companies match - so you never miss a potential opportunity.

Next Steps

With sentiment split between upside potential and the risks flagged so far, this is a moment to move quickly and test the story against the facts by weighing up the 2 key rewards and 2 important warning signs.

Looking for more investment ideas?

If CME Group is on your radar, do not stop there. Broaden your watchlist with other clear, data backed ideas that could suit your investment style.

• Zero in on potential value opportunities by scanning 53 high quality undervalued stocks that combine quality fundamentals with pricing that may still look reasonable.
• Strengthen your income focus by reviewing 12 dividend fortresses that pair higher yields with an emphasis on resilience.
• Prioritise capital protection first by using the 73 resilient stocks with low risk scores to see companies that score well on stability metrics.

This article by Simply Wall St is general in nature. We provide commentary based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. We aim to bring you long-term focused analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material. Simply Wall St has no position in any stocks mentioned.